Journal of Medicinal Chemistry p. 9768 - 9772 (2015)
Update date:2022-08-04
Topics:
Genin, Michael J.
Bueno, Ana B.
Agejas Francisco, Javier
Manninen, Peter R.
Bocchinfuso, Wayne P.
Montrose-Rafizadeh, Chahrzad
Cannady, Ellen A.
Jones, Timothy M.
Stille, John R.
Raddad, Eyas
Reidy, Charles
Cox, Amy
Michael, M. Dodson
Michael, Laura F.
The farnesoid X receptor (FXR) is a member of the "metabolic" subfamily of nuclear receptors. Several FXR agonists have been reported in the literature to have profound effects on plasma lipids in animal models. To discover novel and effective therapies for dyslipidemia and atherosclerosis, we have developed a series of potent FXR agonists that robustly lower plasma LDL and vLDL in LDLr-/- mice. To this end the novel piperidinylisoxazole system LY2562175 was discovered. This molecule is a potent and selective FXR agonist in vitro and has robust lipid modulating properties, lowering LDL and triglycerides while raising HDL in preclinical species. The preclinical ADME properties of LY2562175 were consistent with enabling once daily dosing in humans, and it was ultimately advanced to the clinic for evaluation in humans. The synthesis and biological profile of this molecule is discussed.
View MoreWuxi Morality Chemical Co., Ltd(expird)
Contact:
Address:B/7F, 321th WuYun Rd, Wanda Plaza, Wuxi City, 214174, China
Hubei Xinjing New Material Co.,Ltd
Contact:+86-27-83313147
Address:Room402.#Bthe 7th,Headquarter of Huifeng Corporation Qiaokou District,Wuhan China
Hebei Kangtai Pharmaceutical Co.,Ltd
Contact:+86-0317-3512963
Address:Wugang Road,Mengcun of Cangzhou City,Hebei Province ,China
website:http://www.np-chem.com
Contact:0086-25-52346877
Address:199, Jian Ye Road, Nanjing, China
website:http://www.orchid-chem.com
Contact:+86-571-85395792
Address:607, North Zhongshan Road, Hangzhou 310000 China
Doi:10.3987/COM-08-S(N)118
(2008)Doi:10.1039/b816104f
(2008)Doi:10.1016/0008-6215(86)85071-6
(1986)Doi:10.1039/b810600b
(2008)Doi:10.1002/ardp.200800034
(2008)Doi:10.1016/j.jorganchem.2008.09.063
(2009)